Page not found

Integrative Physiology & Pharmacology Ph.D. Program at Wake Forest University


Wake Forest University Graduate School » Integrative Physiology & Pharmacology Ph.D. Program

Jeffrey A. Katula, Ph.D.

Jeffrey A. Katula, Ph.D.
Education
  • AB. Augustana College, Rock Island, IL, 1992, Psychology
  • MA. Loyola University Chicago, IL, 1995, Counseling Psychology
  • Ph.D. University of Illinois, Urbana-Champaign, 1999, Kinesiology
WFU Courses: HES 262:  Statistics for the Health Sciences HES 312:  Health Psychology HES 715:  Experimental Design

 

 

Healthy Living Partnerships to Prevent Diabetes (HELP PD). The goal of this project is to translate knowledge regarding the prevention of type 2 DM into practice in the community. This project is testing the effectiveness of a group-based intensive lifestyle behavioral intervention incorporating professional counselors and community health workers delivered in the community setting via an existing Diabetes Care Center (DCC) in preventing the onset of type 2 DM. This study is funded by NIDDK. Seniors Health and Activity Research Program-Pilot (SHARP-P). The goal of the project is to develop and conduct a randomized clinical trial to assess whether a multi-factorial intervention involving physical activity and cognitive training reduces the risk of significant cognitive decline in older individuals. This study is funded by NIA Lifestyle Interventions and Independence for Elders (LIFE) Based upon promising results from a pilot study among 424 sedentary older adults who were randomized to a physical activity intervention or a successful aging health education intervention, a Phase 3 multi-center randomized controlled trial is being conducted to compare a moderate-intensity physical activity program to a successful aging health education program in 1,600 sedentary older adults who are followed for an average of 2.7 years. The primary aim is to assess the long-term effects of the proposed interventions on the primary outcome of major mobility disability, defined as inability to walk 400 m. Secondary aims focus on assessing the relative effects of the interventions on the following outcomes: cognitive function; serious fall injuries; persistent mobility disability; the combined outcome of major mobility disability or death; disability in activities of daily living; cardiovascular and pulmonary events; and cost-effectiveness. Tertiary aims relate to assessing the relative effects of the interventions on (a) the combined outcome of mild cognitive impairment or dementia and (b) physical performance within pre-specified subgroups defined on the basis of race, gender and baseline physical performance. This trial will provide definitive evidence regarding whether lifestyle modification interventions are effective and practical for preventing major mobility disability. Eight sites around the country participate in the LIFE study. Action to Control Cardiovascular Risk in Diabetes (ACCORD) The overall goal of the ACCORD trial is to examine the effects of intensive control of glycemia and other CVD risk factors on CVD event rates in diabetic patients by testing three complementary medical treatment strategies for Type II diabetes. This study is funded by NHLBI, NIDDK, NEI, and CDC.